NovoCure Limited (NASDAQ:NVCR) previous close was $216.79 while the outstanding shares total 102.63M. The firm has a beta of 1.07, a 12-month trailing P/E ratio
NovoCure Limited (NASDAQ:NVCR) stock’s Relative Strength Index (RSI) is 71.31, with weekly volatility at 3.65% and ATR at 8.35. The NVCR stock’s 52-week price range
NovoCure Limited (NASDAQ:NVCR) Relative Strength Index (RSI) is 54.85, with weekly volatility at 3.57% and ATR at 8.96. The NVCR stock’s 52-week price range has
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
© 2024, Fueled by Smart TechOne
